These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 12941781)
1. Effects of rosuvastatin on nitric oxide-dependent function in aorta and corpus cavernosum of diabetic mice: relationship to cholesterol biosynthesis pathway inhibition and lipid lowering. Nangle MR; Cotter MA; Cameron NE Diabetes; 2003 Sep; 52(9):2396-402. PubMed ID: 12941781 [TBL] [Abstract][Full Text] [Related]
2. Looking to the future: diabetic neuropathy and effects of rosuvastatin on neurovascular function in diabetes models. Cameron N; Cotter M; Inkster M; Nangle M Diabetes Res Clin Pract; 2003 Jul; 61 Suppl 1():S35-9. PubMed ID: 12880693 [TBL] [Abstract][Full Text] [Related]
3. A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid. Stalker TJ; Lefer AM; Scalia R Br J Pharmacol; 2001 Jun; 133(3):406-12. PubMed ID: 11375257 [TBL] [Abstract][Full Text] [Related]
4. Effects of chelator treatment on aorta and corpus cavernosum from diabetic rats. Keegan A; Cotter MA; Cameron NE Free Radic Biol Med; 1999 Sep; 27(5-6):536-43. PubMed ID: 10490273 [TBL] [Abstract][Full Text] [Related]
5. Effects of diabetes and treatment with the antioxidant alpha-lipoic acid on endothelial and neurogenic responses of corpus cavernosum in rats. Keegan A; Cotter MA; Cameron NE Diabetologia; 1999 Mar; 42(3):343-50. PubMed ID: 10096788 [TBL] [Abstract][Full Text] [Related]
6. In-vitro effects of PDE5 inhibitor and statin treatment on the contractile responses of experimental MetS rabbit's cavernous smooth muscle. Erden Y; Korgalı E; Dundar G; Ayan S; Gokce G; Yildirim S; Gultekin EY Arch Ital Urol Androl; 2014 Mar; 86(1):33-8. PubMed ID: 24704929 [TBL] [Abstract][Full Text] [Related]
9. Protein kinase C beta inhibition and aorta and corpus cavernosum function in streptozotocin-diabetic mice. Nangle MR; Cotter MA; Cameron NE Eur J Pharmacol; 2003 Aug; 475(1-3):99-106. PubMed ID: 12954365 [TBL] [Abstract][Full Text] [Related]
10. Chronic treatment with taurine ameliorates diabetes-induced dysfunction of nitric oxide-mediated neurogenic and endothelium-dependent corpus cavernosum relaxation in rats. Dalaklioglu S; Kuscu N; Celik-Ozenci C; Bayram Z; Nacitarhan C; Ozdem SS Fundam Clin Pharmacol; 2014 Aug; 28(4):394-404. PubMed ID: 23848484 [TBL] [Abstract][Full Text] [Related]
11. HMG-CoA reductase inhibitor improves endothelial dysfunction in spontaneous hypertensive rats via down-regulation of caveolin-1 and activation of endothelial nitric oxide synthase. Suh JW; Choi DJ; Chang HJ; Cho YS; Youn TJ; Chae IH; Kim KI; Kim CH; Kim HS; Oh BH; Park YB J Korean Med Sci; 2010 Jan; 25(1):16-23. PubMed ID: 20052342 [TBL] [Abstract][Full Text] [Related]
12. Effects of the peroxynitrite decomposition catalyst, FeTMPyP, on function of corpus cavernosum from diabetic mice. Nangle MR; Cotter MA; Cameron NE Eur J Pharmacol; 2004 Oct; 502(1-2):143-8. PubMed ID: 15464100 [TBL] [Abstract][Full Text] [Related]
13. Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy. Ii M; Nishimura H; Kusano KF; Qin G; Yoon YS; Wecker A; Asahara T; Losordo DW Circulation; 2005 Jul; 112(1):93-102. PubMed ID: 15983249 [TBL] [Abstract][Full Text] [Related]
14. Improved endothelial function and reduced platelet activation by chronic HMG-CoA-reductase inhibition with rosuvastatin in rats with streptozotocin-induced diabetes mellitus. Schäfer A; Fraccarollo D; Vogt C; Flierl U; Hemberger M; Tas P; Ertl G; Bauersachs J Biochem Pharmacol; 2007 May; 73(9):1367-75. PubMed ID: 17270148 [TBL] [Abstract][Full Text] [Related]
15. Direct vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor. Jones SP; Gibson MF; Rimmer DM; Gibson TM; Sharp BR; Lefer DJ J Am Coll Cardiol; 2002 Sep; 40(6):1172-8. PubMed ID: 12354446 [TBL] [Abstract][Full Text] [Related]
16. Erectile Dysfunction and Altered Contribution of KCa1.1 and KCa2.3 Channels in the Penile Tissue of Type-2 Diabetic db/db Mice. Comerma-Steffensen S; Prat-Duran J; Mogensen S; Fais R; Pinilla E; Simonsen U J Sex Med; 2022 May; 19(5):697-710. PubMed ID: 35321830 [TBL] [Abstract][Full Text] [Related]
17. Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice. Laufs U; Gertz K; Dirnagl U; Böhm M; Nickenig G; Endres M Brain Res; 2002 Jun; 942(1-2):23-30. PubMed ID: 12031849 [TBL] [Abstract][Full Text] [Related]
18. Erectile Dysfunction and Altered Contribution of KCa1.1 and KCa2.3 Channels in the Penile Tissue of Type-2 Diabetic db/db Mice. Comerma-Steffensen S; Prat-Duran J; Mogensen S; Fais R; Pinilla E; Simonsen U J Sex Med; 2022 May; 19(5):697-710. PubMed ID: 37057569 [TBL] [Abstract][Full Text] [Related]
19. Long-term administration of rosuvastatin prevents contractile and electrical remodelling of diabetic rat heart. Ozturk N; Yaras N; Ozmen A; Ozdemir S J Bioenerg Biomembr; 2013 Aug; 45(4):343-52. PubMed ID: 23640692 [TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribose) polymerase inhibition reverses nitrergic neurovascular dysfunctions in penile erectile tissue from streptozotocin-diabetic mice. Nangle MR; Cotter MA; Cameron NE J Sex Med; 2010 Oct; 7(10):3396-403. PubMed ID: 20456626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]